GreenLight SPAC Presentation Deck
Summary Risk Factors
Risks relating to the proposed business combination:
• GreenLight has a limited operating history, which makes it difficult to evaluate our current business and prospects and increases
the risk of investment.
• We have a history of net losses, and we may not achieve or maintain profitability.
• If we do not develop and introduce new products that obtain regulatory approval and achieve market acceptance, we will not be
able to generate or grow revenues.
• We will incur significant expenses to develop products and cannot assure you that we can achieve a return on that investment.
We face significant competition and many of our competitors have substantially greater financial, technical, supply chain and
other resources than we do.
•
• Our business, financial results and reputation in the marketplace may suffer upon the loss of a significant customer or partner.
• Our ability to bring agricultural products to market successfully depends on achieving and maintaining the price competitiveness
of RNA anticipated to be produced by our RNA platform.
• We are subject to numerous and rapidly changing federal, state, local and international laws and regulations related to our
products, and the failure to comply with any of these laws and regulations, or failure to comply with new or changed laws and
regulations, could adversely affect our business and our financial condition.
• Information technology systems are critical to our business and interruptions, or security incidents associated with those systems
could cause significant disruption to our business as well as financial and reputational harm.
• Loss of key personnel could delay our programs, harm our development efforts and adversely affect our business and results of
operations.
Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential.
54View entire presentation